Search Login Register
HIV Infections
(HIV Infection)
Summary
Description:
Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
Also Known As:
HIV Infection; Infection, HIV; HTLV III Infections; HTLV III LAV Infections; HTLV-III Infection Show All >>
Networked: 14900
relevant articles (784 outcomes,
1594 trials/studies)
for this Disease
Key Drugs and Agents for HIV Infections
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Zidovudine (Retrovir)
:
35 outcomes 83 studies in 491 results
:
FDA 42
Generic
-
Protease Inhibitors (Protease Inhibitor)
:
33 outcomes 25 studies in 414 results
: IBA
-
tenofovir
:
16 outcomes 37 studies in 156 results
:
FDA 1
-
Antigens
:
16 outcomes 30 studies in 480 results
: IBA
-
Vaccines
:
15 outcomes 34 studies in 174 results
: IBA
-
Antibodies
:
14 outcomes 35 studies in 526 results
: IBA
-
Ritonavir (Norvir)
:
14 outcomes 17 studies in 133 results
:
FDA 11
-
Thalidomide (Thalomid)
:
14 outcomes 9 studies in 38 results
:
FDA 2
-
RNA (Ribonucleic Acid)
:
13 outcomes 34 studies in 387 results
: IBA
-
Biological Markers (Surrogate Marker)
:
12 outcomes 45 studies in 226 results
: IBA
Show All >>
Diseases Related to HIV Infections
-
Acquired Immunodeficiency Syndrome (AIDS)
-
Infection
-
Sexually Transmitted Diseases (Sexually Transmitted Disease)
-
Tuberculosis (Tuberculoses)
-
Neoplasms (Cancer)
Show All >>
Key Therapies for HIV Infections
Efficacy Chart >>
-
Highly Active Antiretroviral Therapy (HAART)
:
123 outcomes 112 studies in 1432 results
-
Condoms (Condom)
:
50 outcomes 59 studies in 675 results
-
Drug Therapy (Chemotherapy)
:
30 outcomes 14 studies in 315 results
-
Art Therapy
:
26 outcomes 21 studies in 356 results
-
Male Circumcision (Circumcision)
:
23 outcomes 61 studies in 218 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.